Tiedemann Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Tiedemann Advisors's LLY Position: Q3 2023 in Review
Tiedemann Advisors increased its Eli Lilly (LLY) stake by 833% in Q3 2023, buying an estimated $2.44M and bringing the position to 5,308 shares worth $2.85M. The position accounts for 0.12% of the portfolio, ranked #65.
Tiedemann Advisors first reported a position in LLY in Q1 2017 and has held it in 17 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Tiedemann Advisors held 5,308 shares of Eli Lilly worth $2.85M as of Q3 2023.
- Tiedemann Advisors bought 4,739 Eli Lilly shares in Q3 2023, an estimated $2.44M.
- Eli Lilly made up 0.12% of Tiedemann Advisors's portfolio in Q3 2023, its #65 holding.
- Tiedemann Advisors first reported a position in Eli Lilly in Q1 2017 and has held it in 17 quarters since.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.